Successful Treatment of Intractable Fluid Retention Using Tolvaptan After Treatment for Postoperative Mediastinitis in a Patient With a Left Ventricular Assist Device-Reference-Cited by-同舟云学术

Successful Treatment of Intractable Fluid Retention Using Tolvaptan After Treatment for Postoperative Mediastinitis in a Patient With a Left Ventricular Assist Device

Published:2015 Issue:5 Volume:56 Page:574-577
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Kimura Mitsutoshi¹,Nawata Kan¹,Kinoshita Osamu¹,Hatano Masaru²,Imamura Teruhiko³,Kinugawa Koichiro³,Ono Minoru¹

Affiliation:

1. Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo

2. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

3. Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/56/5/56_14-412/_pdf

Reference18 articles.

1. 1. Kimura M, Kinoshita O, Nawata K, et al. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan. J Cardiol 2015; 65: 383-9.

2. 2. Ono M, Nishimura T, Kinoshita O, et al. Improved survival in patients with continuous-flow ventricular assist device for bridge to heart transplantation. Transplant Proc 2013; 45: 2017-8.

3. 3. Sakaguchi T, Matsumiya G, Yoshioka D, et al. DuraHeart^TM magnetically levitated left ventricular assist device: Osaka University experience. Circ J 2013; 77: 1736-41.

4. 4. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008; 371: 1624-32. (Review)

5. 5. Yamamura Y, Nakamura S, Itoh S, et al. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther 1998; 287: 860-7.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices;ASAIO Journal;2020-03

2. Does Tolvaptan Have Any Therapeutic Roles in Patients With Left Ventricular Assist Device?;ASAIO Journal;2019-09

3. Yes or No. Tolvaptan May Be a Potential Alternative to Loop Diuretics in Patients With Left Ventricular Assist Device;ASAIO Journal;2019-09

4. Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan;Journal of Anaesthesiology Clinical Pharmacology;2018

5. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device;International Heart Journal;2017